How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in Prostate Cancer Diagnosis, Recurrence, and Metastasis: a Prospective Study
Description:
To prospectively evaluate the radiodrug biodistribution of a novel PET imaging agent [18F]AlF-PSMA-N5 in different organs of prostate cancer patients and its diagnostic efficacy in the diagnosis, recurrence and metastasis of prostate cancer, and to compare with [18F]F-DCFPyL.
Sponsor:
Anhui Provincial Hospital
Contacts:
Qiang Xie, MDxieqiang1980@ustc.edu.cn
13721108043
Government Study Link:
NCT06756334 - Click here to see study onClinicalTrials.gov
[18F]AlF-PSMA-N5
Isotope(s):
Target(s):
- PSMA
